AstraZeneca Pharmaceuticals Inc. filed a motion on Wednesday to block Dr. Christopher Reist from testifying for Handa Pharmaceuticals LLC, a rival pharmaceutical company, in an ongoing patent infringement case over AstraZeneca’s Seroquel XR®. Dr. Reist worked on the clinical trials for Seroquel XR® between 2001 and 2007 as one of it’s paid speakers. Handa has selected Dr. Reist as an expert witness in the infringement case, something AstraZeneca states will create a conflict of interest. AstraZeneca is represented by Finnegan.
Media Mention
Finnegan Shortlisted for the 2024 Asian Legal Business Japan Law Awards
April 26, 2024
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.